skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab


Citation Formats

Gasser, Pascal, Tarchevskaya, Svetlana S., Guntern, Pascal, Brigger, Daniel, Ruppli, Rahel, Zbären, Noemi, Kleinboelting, Silke, Heusser, Christoph, Jardetzky, Theodore S., and Eggel, Alexander. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. United States: N. p., 2020. Web. doi:10.1038/s41467-019-13815-w.
Gasser, Pascal, Tarchevskaya, Svetlana S., Guntern, Pascal, Brigger, Daniel, Ruppli, Rahel, Zbären, Noemi, Kleinboelting, Silke, Heusser, Christoph, Jardetzky, Theodore S., & Eggel, Alexander. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. United States. doi:10.1038/s41467-019-13815-w.
Gasser, Pascal, Tarchevskaya, Svetlana S., Guntern, Pascal, Brigger, Daniel, Ruppli, Rahel, Zbären, Noemi, Kleinboelting, Silke, Heusser, Christoph, Jardetzky, Theodore S., and Eggel, Alexander. Wed . "The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab". United States. doi:10.1038/s41467-019-13815-w.
@article{osti_1598033,
title = {The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab},
author = {Gasser, Pascal and Tarchevskaya, Svetlana S. and Guntern, Pascal and Brigger, Daniel and Ruppli, Rahel and Zbären, Noemi and Kleinboelting, Silke and Heusser, Christoph and Jardetzky, Theodore S. and Eggel, Alexander},
abstractNote = {},
doi = {10.1038/s41467-019-13815-w},
journal = {Nature Communications},
issn = {2041-1723},
number = 1,
volume = 11,
place = {United States},
year = {2020},
month = {1}
}

Works referenced in this record:

Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins.
journal, January 1992

  • Beavil, A. J.; Edmeades, R. L.; Gould, H. J.
  • Proceedings of the National Academy of Sciences, Vol. 89, Issue 2
  • DOI: 10.1073/pnas.89.2.753

High affinity targeting of CD23 inhibits IgE synthesis in human B cells: High affinity targeting of CD23
journal, July 2015

  • Fellmann, Marc; Buschor, Patrick; Röthlisberger, Silvan
  • Immunity, Inflammation and Disease, Vol. 3, Issue 4
  • DOI: 10.1002/iid3.72

Targeting IgE in allergic disease
journal, October 2018


CD23 Trimers Are Preassociated on the Cell Surface Even in the Absence of Its Ligand, IgE
journal, January 2004


Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells
journal, June 2014

  • Eggel, Alexander; Baravalle, Günther; Hobi, Gabriel
  • Journal of Allergy and Clinical Immunology, Vol. 133, Issue 6
  • DOI: 10.1016/j.jaci.2014.02.005

High-Affinity IgE Receptors on Dendritic Cells Exacerbate Th2-Dependent Inflammation
journal, May 2011

  • Sallmann, Eva; Reininger, Bärbel; Brandt, Sabine
  • The Journal of Immunology, Vol. 187, Issue 1
  • DOI: 10.4049/jimmunol.1003392

Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
journal, April 2012

  • Chu, Seung Y.; Horton, Holly M.; Pong, Erik
  • Journal of Allergy and Clinical Immunology, Vol. 129, Issue 4
  • DOI: 10.1016/j.jaci.2011.11.029

Omalizumab: Practical considerations regarding the risk of anaphylaxis
journal, December 2010

  • Kim, Harold L.; Leigh, Richard; Becker, Allan
  • Allergy, Asthma & Clinical Immunology, Vol. 6, Issue 1
  • DOI: 10.1186/1710-1492-6-32

The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
journal, July 2012

  • Palakodeti, Aparna; Sandstrom, Andrew; Sundaresan, Lakshmi
  • Journal of Biological Chemistry, Vol. 287, Issue 39
  • DOI: 10.1074/jbc.M112.384354

Accelerated disassembly of IgE–receptor complexes by a disruptive macromolecular inhibitor
journal, October 2012

  • Kim, Beomkyu; Eggel, Alexander; Tarchevskaya, Svetlana S.
  • Nature, Vol. 491, Issue 7425
  • DOI: 10.1038/nature11546

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses
journal, October 2016

  • Gauvreau, Gail M.; Arm, Jonathan P.; Boulet, Louis-Philippe
  • Journal of Allergy and Clinical Immunology, Vol. 138, Issue 4
  • DOI: 10.1016/j.jaci.2016.02.027

Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI
journal, April 2011

  • Holdom, Mary D.; Davies, Anna M.; Nettleship, Joanne E.
  • Nature Structural & Molecular Biology, Vol. 18, Issue 5
  • DOI: 10.1038/nsmb.2044

Structural Changes in the Lectin Domain of CD23, the Low-Affinity IgE Receptor, upon Calcium Binding
journal, June 2006

  • Wurzburg, Beth A.; Tarchevskaya, Svetlana S.; Jardetzky, Theodore S.
  • Structure, Vol. 14, Issue 6
  • DOI: 10.1016/j.str.2006.03.017

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
journal, April 2017

  • Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.
  • Journal of Biological Chemistry, Vol. 292, Issue 24
  • DOI: 10.1074/jbc.M117.776476

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain
journal, February 2000

  • Nakamura, Takehiko; Kloetzer, William S.; Brams, Peter
  • International Journal of Immunopharmacology, Vol. 22, Issue 2
  • DOI: 10.1016/S0192-0561(99)00068-5

Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation
journal, March 2015

  • Palaniyandi, S.; Liu, X.; Periasamy, S.
  • Mucosal Immunology, Vol. 8, Issue 6
  • DOI: 10.1038/mi.2015.16

Negative feedback regulation of IgE synthesis by murine CD23
journal, June 1994

  • Yu, Philipp; Kosco-Vilbois, Marie; Richards, Mark
  • Nature, Vol. 369, Issue 6483
  • DOI: 10.1038/369753a0

A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma
journal, February 2014

  • Cohen, E. Suzanne; Dobson, Claire L.; Käck, Helena
  • mAbs, Vol. 6, Issue 3
  • DOI: 10.4161/mabs.28394

A Fluorescent Biosensor Reveals Conformational Changes in Human Immunoglobulin E Fc: IMPLICATIONS FOR MECHANISMS OF RECEPTOR BINDING, INHIBITION, AND ALLERGEN RECOGNITION
journal, March 2012

  • Hunt, James; Keeble, Anthony H.; Dale, Robert E.
  • Journal of Biological Chemistry, Vol. 287, Issue 21
  • DOI: 10.1074/jbc.M111.331967

Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
journal, July 2000

  • Garman, Scott C.; Wurzburg, Beth A.; Tarchevskaya, Svetlana S.
  • Nature, Vol. 406, Issue 6793
  • DOI: 10.1038/35018500

Ligelizumab for Chronic Spontaneous Urticaria
journal, October 2019

  • Maurer, Marcus; Giménez-Arnau, Ana M.; Sussman, Gordon
  • New England Journal of Medicine, Vol. 381, Issue 14
  • DOI: 10.1056/NEJMoa1900408

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

IgE in allergy and asthma today
journal, March 2008

  • Gould, Hannah J.; Sutton, Brian J.
  • Nature Reviews Immunology, Vol. 8, Issue 3
  • DOI: 10.1038/nri2273

Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice
journal, June 2010

  • Brightbill, Hans D.; Jeet, Surinder; Lin, Zhonghua
  • Journal of Clinical Investigation, Vol. 120, Issue 6
  • DOI: 10.1172/JCI40141

IgE binds asymmetrically to its B cell receptor CD23
journal, March 2017

  • Dhaliwal, Balvinder; Pang, Marie O. Y.; Keeble, Anthony H.
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep45533

Anti-CD23 monoclonal antibody inhibits germline Cε transcription in B cells
journal, March 2002

  • Yabuuchi, Shingo; Nakamura, Takehiko; Kloetzer, William S.
  • International Immunopharmacology, Vol. 2, Issue 4
  • DOI: 10.1016/S1567-5769(01)00187-4

Approaches to target IgE antibodies in allergic diseases
journal, November 2018


Therapeutic potential of anti-IgE antibodies
journal, December 1997


Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor Fc RI
journal, July 2012

  • Dhaliwal, B.; Yuan, D.; Pang, M. O. Y.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 31
  • DOI: 10.1073/pnas.1207278109

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
journal, August 2001

  • Busse, William; Corren, Jonathan; Lanier, Bobby Quentin
  • Journal of Allergy and Clinical Immunology, Vol. 108, Issue 2
  • DOI: 10.1067/mai.2001.117880

Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII
journal, October 2015

  • Sutton, Brian J.; Davies, Anna M.
  • Immunological Reviews, Vol. 268, Issue 1
  • DOI: 10.1111/imr.12340

Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
journal, October 2014

  • Arm, J. P.; Bottoli, I.; Skerjanec, A.
  • Clinical & Experimental Allergy, Vol. 44, Issue 11
  • DOI: 10.1111/cea.12400

Human IgE Synthesis in vitro.: Detection with Monoclonal Antibodies
journal, August 1986


XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells
journal, March 2015

  • Nyborg, Andrew C.; Zacco, Anna; Ettinger, Rachel
  • Cellular & Molecular Immunology, Vol. 13, Issue 3
  • DOI: 10.1038/cmi.2015.19

Murine B Cells Regulate Serum IgE Levels in a CD23-Dependent Manner
journal, September 2010

  • Cheng, Laurence E.; Wang, Zhi-En; Locksley, Richard M.
  • The Journal of Immunology, Vol. 185, Issue 9
  • DOI: 10.4049/jimmunol.1001900

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
journal, May 2016

  • Pennington, Luke F.; Tarchevskaya, Svetlana; Brigger, Daniel
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms11610

A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses
journal, January 2017

  • Zellweger, F.; Gasser, P.; Brigger, D.
  • Allergy, Vol. 72, Issue 8
  • DOI: 10.1111/all.13109

Serum IgE clearance is facilitated by human FcεRI internalization
journal, February 2014

  • Greer, Alexandra M.; Wu, Nan; Putnam, Amy L.
  • Journal of Clinical Investigation, Vol. 124, Issue 3
  • DOI: 10.1172/JCI68964

Conformational Flexibility in Immunoglobulin E-Fc3–4 Revealed in Multiple Crystal Forms
journal, October 2009


DARPins against a functional IgE epitope
journal, October 2010


Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy
journal, April 2005


The development of allergic inflammation
journal, July 2008

  • Galli, Stephen J.; Tsai, Mindy; Piliponsky, Adrian M.
  • Nature, Vol. 454, Issue 7203
  • DOI: 10.1038/nature07204

Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction
journal, January 2018


Treatment strategies for allergy and asthma
journal, February 2008

  • Holgate, Stephen T.; Polosa, Riccardo
  • Nature Reviews Immunology, Vol. 8, Issue 3
  • DOI: 10.1038/nri2262